Delivery Order SPE2DB20D1100-SPE2DB24FB1K8

Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $1.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $6,053.90 order is for 4564029073 - CLOMID 50 MG TABLET UD 30S and does not have a set-aside designation. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $1,275.97 contract is for the supply of CLOMID 50 MG TABLET UD 30S, a pharmaceutical product, with a period of performance through March 28, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of CLOMID 50 MG TABLET UD 30S, a prescription medication. The award, valued at $1,122.45, was made on August 27, 2024, with a completion date of August 28, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, which enables the agency to efficiently procure a comprehensive range of...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide CLOMID 50 MG TABLET UD 30S, a pharmaceutical product, with a completion date of February 27, 2024. The award value is $2,120.42. This delivery order is issued under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of up to $999,999,999.00 and a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation for the supply of CLOMID 50 MG TABLET UD 30S. The award, valued at $9,535.49, is a firm fixed price contract with a period of performance through July 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these medical supplies under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CLOMID 50 MG TABLET UD 30S. The $1,742.82 firm fixed-price contract has a completion date of November 6, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, the prime contractor. The contract is for the supply of CLOMID 50 MG TABLET UD 30S, with a potential value of $2,638.86 and a completion date of February 6, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit organization that provides pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,130.48 firm fixed-price delivery order covers the supply of CLOMID 50 MG TABLET UD 30S, a generic pharmaceutical product. The contract has an ultimate completion date of September 23, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading global pharmaceutical distribution company, to provide Clomid 50 mg tablets. The order has a ceiling value of $1,071.21 and a performance period through March 19, 2024. AmerisourceBergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA to supply a comprehensive range of pharmaceutical products and medical supplies to military...
This federal contract award, with the ID SPE2DX15D6041|SPE2DX24FBVNA, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,200.64 delivery order is for the supply of 4565117481 CLOMID 50 MG TABLET UD 30S, a prescription medication. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FB1K8
    Delivery Order

This is a firm fixed-price delivery order (SPE2DB20D1100|SPE2DB24FB1K8) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4564184328 - CLOMID 50 MG TABLET UD 30S. The award has a ceiling value of $1,250.44 and a performance period through April 8, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order does not have a set-aside designation.

Generated 7/5/24, 9:23 AM